Understanding the Postpartum Pain Experience in Women of Minority Race/Ethnicity
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04601246 |
|
Recruitment Status :
Completed
First Posted : October 23, 2020
Last Update Posted : January 4, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Pain Management Opioid Use Postpartum Health Cesarean Delivery |
Opioid misuse has been declared a national emergency in the United States. Although the opioid epidemic has touched all communities, there is a differential impact based on race and ethnicity. In particular, data has shown that individuals of minority race/ ethnicity are less likely to receive an opioid for pain management than non- Hispanic white individuals. As birth is the most common reason for hospitalization, women of reproductive age are particularly vulnerable to opioid exposure and to experiencing disparities in pain management. Indeed, our data have demonstrated the high frequency of inpatient and outpatient opioid use and wide variation in management of postpartum pain. Notably, data has shown that, despite reporting higher levels of pain postpartum, minority race/ ethnicity women receive less opioid treatment as inpatients and are less frequently prescribed an opioid upon hospital discharge. Despite this plethora of quantitative data, few reports have explored women's perspectives on the postpartum pain experience and disparities therein.
The investigators propose a qualitative study of women's experience with pain management in the postpartum period. This proposal aims to fill an unmet need for a systematic, in-depth, and unbiased evaluation of women's postpartum pain experiences, with a focus on racial/ ethnic disparities. The investigators will conduct in-depth interviews on the postpartum pain experience among low-income women who have undergone cesarean delivery.
The first interview will be approximately 60 minutes long and will take place during the postpartum hospitalization during days 1 through 4. All efforts will be made to interview the participant at a time when she is comfortable, free of distraction, and not experiencing any medical complications. Interviews will be conducted privately in the participant's hospital room. All guests will be asked to leave the room for the interview and clinical interruptions will be minimized. Interviewers will be trained in the confidential and sensitive conduct of interviews about these topics. Interviews will be conducted by experienced research personnel trained to perform in-depth, unbiased, professional interviews and who are fluent in English and Spanish. The second interview will be by phone for 2 to 4 weeks after hospital discharge that will last approximately 45 minutes.
Interview topics will address identify themes related to autonomy, respect, cultural views on pain management, feeling heard/valued, communication with care team, understanding pain management options, medication administration timing, and perceptions of provider judgment related to opioids. This interview will also ask participants to self-identify their race and ethnicity. Interviews will be audio-recorded. After completion of the interviews, the digital audio files will be professionally transcribed prior to analysis.
This project takes an innovative approach in targeting health disparities in racial/ ethnic minorities, who are disproportionately affected by maternal mortality and severe maternal morbidity. Optimizing postpartum health, reducing opioid overuse, and reducing disparities in care and outcomes are critical goals of major professional societies and the NICHD 2020 strategic plan. Understand the postpartum pain experience will inform future implementation studies by providing an essential missing piece: women's voices and perspectives. Furthermore, this work aims to identify root causes of racial/ ethnic disparities in postpartum opioid use and pain management and allow a foundation from which to enact systems and policies which guard against such disparities.
| Study Type : | Observational |
| Actual Enrollment : | 49 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | The Postpartum Pain Experience - Understanding the Postpartum Pain Experience in Women of Minority Race/Ethnicity |
| Actual Study Start Date : | December 1, 2020 |
| Actual Primary Completion Date : | December 1, 2021 |
| Actual Study Completion Date : | December 30, 2021 |
- Themes of pain management and perceived attitudes regarding opioid use for postpartum pain management [ Time Frame: 24-48 hours after delivery ]Through analysis of qualitative interviews, themes such as satisfaction, engagement, respect, and preferences will be reviewed, and the constant comparative method will be applied.
- Themes of pain management and perceived attitudes regarding opioid use for postpartum pain management [ Time Frame: 2-4 weeks after hospital discharge ]Through analysis of qualitative interviews, themes such as satisfaction, engagement, respect, and preferences will be reviewed, and the constant comparative method will be applied.
- Differences in postpartum pain experiences by maternal race/ethnicity [ Time Frame: 24-48 hours after delivery ]Through analysis of qualitative interviews, we will evaluate how experiences of postpartum pain management and perceptions of provider attitudes vary across self-identified race/ethnicity.
- Differences in postpartum pain experiences by maternal race/ethnicity [ Time Frame: 2-4 weeks after hospital discharge ]Through analysis of qualitative interviews, we will evaluate how experiences of postpartum pain management and perceptions of provider attitudes vary across self-identified race/ethnicity.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 16 Years and older (Child, Adult, Older Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Pregnant (any plurality) delivering at or after 20 weeks of gestation OR postpartum (during hospitalization), regardless of perinatal outcome
- 16 years or older
- Low-income socioeconomic status (publicly funded prenatal care or uninsured)
- Ability to speak and read English and/or Spanish
- Planned or experienced cesarean delivery
Exclusion Criteria:
- HIV (as these patients already receive intensive social support and navigation-like services)
- Prior pregnancy in which individual declined participation
- Recent COVID-19 positive test, unless patient is asymptomatic and can conduct the study visit via video conference
- Contraindication to opioid or non-steroidal anti-inflammatory drugs
- Non-opioid naïve (defined as ≥3 opioid prescriptions in the year prior to recruitment)
- Use of general anesthesia for delivery
- Postpartum intensive care unit admission
- Known substance use disorder
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04601246
| United States, Illinois | |
| Northwestern Memorial Hospital | |
| Chicago, Illinois, United States, 60611 | |
| Principal Investigator: | Nevert Badreldin, MD | Northwestern University |
| Responsible Party: | Nevert Badreldin, Assistant Professor of Obstetrics and Gynecology (Maternal Fetal Medicine), Northwestern University |
| ClinicalTrials.gov Identifier: | NCT04601246 |
| Other Study ID Numbers: |
3R01HD098178-02S1 ( U.S. NIH Grant/Contract ) 3R01HD098178-02S1 ( U.S. NIH Grant/Contract ) |
| First Posted: | October 23, 2020 Key Record Dates |
| Last Update Posted: | January 4, 2022 |
| Last Verified: | January 2022 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

